Dr. Robert Motl, Ph.D
Claim this profileUniversity of Illinois at Chicago
Studies Multiple Sclerosis
Studies Motor Skills
5 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Robert Motl, Ph.D is currently running
Exercise Training Program
for Multiple Sclerosis
The proposed project involves a high-quality randomized controlled (RCT) design that examines the effects of a remotely-delivered, racially-tailored exercise training program for immediate and sustained improvement in walking dysfunction, symptoms, and health-related quality of life (HRQOL) among African-Americans with MS residing in rural environments. The primary analysis will test the hypothesis that those who are randomly assigned into the intervention condition (i.e., exercise training) will demonstrate (a) improvements in outcomes from baseline that (b) are sustained over 4-months of follow-up compared with those in the control condition (i.e., stretching).
Recruiting0 awards N/A
Online Physical Activity Program
for Multiple Sclerosis
We propose a highly-informed, well-designed randomized controlled trial (RCT) that is critical for providing Class I evidence regarding an Internet-delivered physical activity (PA) intervention as a behavioral approach for managing slowed cognitive processing speed (CPS; the most common and perhaps most burdensome MS-related cognitive impairment) and its second learning and memory, symptomatic, and quality of life (QOL) correlates among fully-ambulatory persons with multiple sclerosis (MS) who present with CPS impairment. Such an approach will involve a single-blind, RCT that examines the effects of a remotely-delivered, Internet-based PA intervention compared with an active control condition for yielding immediate and sustained improvements in CPS, learning and memory, symptomatic, and QOL outcomes among persons with mild MS-related ambulatory impairment who demonstrate impaired CPS. The primary outcome is the raw (unadjusted), oral Symbol Digit Modalities Test (SDMT) score as a neuropsychological measure of CPS, and this will be collected remotely via screen-sharing technology. The secondary outcomes include an objective neuropsychological measure of learning and memory (California Verbal Learning Test-II) collected remotely via screen-sharing technology, self-report measures of fatigue (Fatigue Severity Scale), depressive symptoms and anxiety (Hospital Anxiety and Depression Scale), pain (Short-Form, McGill Pain Questionnaire) and QOL (Multiple Sclerosis Impact Scale-29) that will be captured remotely using Qualtrics. The tertiary outcome is accelerometry as an objective, device-based measure of steps/day that will be delivered and returned via pre-paid, pre-addressed envelopes through the United States Postal Service for generating a minimal clinically important difference value that guides the prescription of free-living PA for managing CPS impairment in clinical practice.
Recruiting0 awards N/A11 criteria
More about Robert Motl, Ph.D
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Robert Motl, Ph.D has experience with
- GET Up PD
- Behavioral Intervention For Physical Activity In MS (BIPAMS)
- Wellness For MS (WellMS)
- FLEX-MS
- POWER-MS
- Exercise Training Program
Breakdown of trials Robert Motl, Ph.D has run
Multiple Sclerosis
Motor Skills
Parkinsonism
Functional Movement Disorder
Extrapyramidal Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Motl, Ph.D specialize in?
Robert Motl, Ph.D focuses on Multiple Sclerosis and Motor Skills. In particular, much of their work with Multiple Sclerosis has involved treating patients, or patients who are undergoing treatment.
Is Robert Motl, Ph.D currently recruiting for clinical trials?
Yes, Robert Motl, Ph.D is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Robert Motl, Ph.D has studied deeply?
Yes, Robert Motl, Ph.D has studied treatments such as GET Up PD, Behavioral Intervention for Physical Activity in MS (BIPAMS), Wellness for MS (WellMS).
What is the best way to schedule an appointment with Robert Motl, Ph.D?
Apply for one of the trials that Robert Motl, Ph.D is conducting.
What is the office address of Robert Motl, Ph.D?
The office of Robert Motl, Ph.D is located at: University of Illinois at Chicago, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois at Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.